| 摘要 |
A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as penciclorivir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections. |
